Skip to Content

Steris PLC

STE: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$162.00ZyrrpjKkszdfqp

Steris Set For Margin Growth As Cantel Costs Roll Off

Narrow-moat Steris ended the fiscal year on a high note with top-line outperformance, and while reported margin was lower on a year-over-year basis, this was mainly due to costs from the Cantel integration, and margin expanded on an adjusted basis. After rolling our model, we are increasing our fair value estimate to $201 per share from $189, and see shares as fairly valued.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of STE so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center